Goldwater Institute sues FDA over Ebola drug protocol
By Angela Gonzales, Phoenix Business Journal, June 10, 2015
The Goldwater Institute is suing the U.S. Food and Drug Administration in an attempt to uncover government secrets.
The FDA denied the Phoenix-based think tank's Freedom of Information Act request for information about the FDA's internal approval process that allowed Americans infected with Ebola to be successfully treated with a drug under development.
Jon Riches, an attorney with the Goldwater Institute, said the FDA told his group it could not give away trade secrets.
"We didn't ask for any proprietary commercial information," he said. "All we asked for was the government process used to approve these drugs. The FDA drug approval process should be open to the scrutiny of the public."
Read more here.